Simponi 50mg Injection

Simponi 50mg injection contains an active component as Golimumab. It is a monoclonal antibody drug used to treat autoimmune diseases, particularly certain inflammatory conditions. It works by targeting and inhibiting a certain protein, which plays a role in causing inflammation in the body. It is used to treat moderate to severe rheumatoid arthritis in adults, often in combination with other disease-modifying antirheumatic drugs (DMARDs). It is also approved for treating psoriatic arthritis, an autoimmune condition affecting joints and skin. It can treat ankylosing spondylitis, a type of arthritis primarily affecting the spine and sacroiliac joints. One of the advantages of this medication is that it offers relatively long dosing intervals compared to other biological medications. Simponi 50mg injection should not be used in patients with known hypersensitivity or severe allergic reactions to the drug.

simponi 50mg Injection is given as an injection by healthcare professionals. The dosage and duration of treatment will be based on the individual's condition and response to the medication and should be determined by a healthcare provider.

Simponi 50mg Injection contains Golimumab, as an active ingredient that belongs to the class of monoclonal TNF inhibitors. It works by inhibiting the TNF-α and TNF-β binding to the cell surface, thereby making the TNF cytokine inactive. This helps reduce inflammation, pain and redness caused by various autoimmune diseases.

COLD CHAIN

1 PFS